Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study

Gonadotropin therapy is commonly used to induce virilization and spermatogenesis in male isolated hypogonadotropic hypogonadism (IHH) patients. In clinical practice, 5.6%–15.0% of male IHH patients show poor responses to gonadotropin treatment; therefore, testosterone (T) supplementation can serve a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yin-Wei, Niu, Yong-Hua, Xu, Hao, Wang, Dao-Qi, Jiang, Hong-Yang, Pokhrel, Gaurab, Wang, Tao, Wang, Shao-Gang, Liu, Ji-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628746/
https://www.ncbi.nlm.nih.gov/pubmed/30604694
http://dx.doi.org/10.4103/aja.aja_107_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628746/
https://www.ncbi.nlm.nih.gov/pubmed/30604694
http://dx.doi.org/10.4103/aja.aja_107_18

Ejemplares similares